Avi Baskin
Papers
1
Total Citations
6
H-Index
1
About
Dr. Avi Baskin is a distinguished urologic oncologist whose research focuses on optimizing outcomes in prostate cancer surgery, particularly through the refinement of radical prostatectomy techniques and postoperative monitoring. His landmark 2021 study, "Residual Benign Prostate Glandular Tissue after Radical Prostatectomy is Not Associated with the Development of Detectable Postoperative Serum Prostate Specific Antigen," fundamentally challenged conventional assumptions about benign glandular tissue at surgical margins. By demonstrating that benign glandular tissue at the margin (BGM) does not correlate with detectable PSA or biochemical recurrence, Dr. Baskin provided critical evidence that helps prevent unnecessary patient anxiety and overtreatment. This work, cited 6 times, has important implications for how clinicians interpret postoperative PSA levels and counsel patients. His contributions extend to advancing precision in surgical pathology assessment and refining the definition of successful oncologic outcomes. Dr. Baskin's research bridges the gap between surgical technique and patient-centered care, offering clarity in a complex clinical scenario. His findings continue to influence urologic practice, ensuring that postoperative surveillance strategies remain evidence-based and focused on true recurrence risk rather than benign findings.
Research Focus
Key Achievements
Top Papers
- 1